Efficacy and safety of valbenazine in Japanese patients with tardive dyskinesia: A multicenter, randomized, double‐blind, placebo‐controlled study ( <scp>J‐KINECT</scp> )-Reference-Cited by-同舟云学术

Efficacy and safety of valbenazine in Japanese patients with tardive dyskinesia: A multicenter, randomized, double‐blind, placebo‐controlled study ( J‐KINECT )

Published:2022-09-17 Issue:11 Volume:76 Page:560-569
ISSN:1323-1316
Container-title:Psychiatry and Clinical Neurosciences
language:en
Short-container-title:Psychiatry Clin Neurosci

Author:

Horiguchi Jun¹,Watanabe Koichiro²^ORCID,Kondo Kazuoki³,Iwatake Atsushi³,Sakamoto Hajime³,Susuta Yutaka³,Masui Hideaki³,Watanabe Yumi³^ORCID

Affiliation:

1. Department of Psychiatry Shimane University Faculty of Medicine Izumo Shimane Japan

2. Department of Neuropsychiatry Kyorin University School of Medicine Mitaka Tokyo Japan

3. Ikuyaku, Integrated Value Development Division Mitsubishi Tanabe Pharma Corporation Osaka Japan

Funder

Mitsubishi Tanabe Pharma Corporation

Publisher

Wiley

Subject

Psychiatry and Mental health,Neurology (clinical),Neurology,General Medicine,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/pcn.13455

Reference34 articles.

1. Medication induced tardive dyskinesia: a review and update;Cornett EM;Ochsner J.,2017

2. Tardive dyskinesia and new antipsychotics

3. Tardive dyskinesia (syndrome): Current concept and modern approaches to its management

4. Historical perspectives on tardive dyskinesia

5. Life‐threatening tardive dyskinesia;Chiu HF;Br. J. Clin. Pract.,1996

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mining of neurological adverse events associated with valbenazine: A post-marketing analysis based on FDA adverse event reporting system;General Hospital Psychiatry;2024-09

2. Efficacy and Safety of Valbenazine in Elderly and Nonelderly Japanese Patients With Tardive Dyskinesia;Journal of Clinical Psychopharmacology;2024-08-27

3. Efficacy and safety of different pharmacological interventions in the treatment of tardive dyskinesia: a systematic review and network meta-analysis;European Journal of Clinical Pharmacology;2024-07-06

4. Sustained Treatment Response and Global Improvements With Long-term Valbenazine in Patients With Tardive Dyskinesia;Journal of Clinical Psychopharmacology;2024-05-20

5. Efficacy and Safety of Valbenazine in Japanese Patients With Tardive Dyskinesia and Schizophrenia/Schizoaffective Disorder or Bipolar Disorder/Depressive Disorder;Journal of Clinical Psychopharmacology;2024-03